Prognostic analysis of RAS -related lncRNAs in liver hepatocellular carcinoma.

Ding Li,Xinxin Fan,Lihua Zuo,Xuan Wu,Yingxi Wu,Yuanyuan Zhang,Fanmei Zou,Zhi Sun,Wenzhou Zhang

Annals of translational medicine（2022）

引用 0|浏览9

暂无评分

摘要

We developed a -related lncRNA risk signature that was highly associated with the prognosis and response to immunotherapy and targeted drugs and which provided novel mechanistic insights into the personalized treatment and potential drug selection for patients with LIHC.

查看译文

关键词

Liver hepatocellular carcinoma (LIHC),RAS,immunotherapy,prognosis,tumor mutation burden

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要